Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c699 |
|---|---|
| Identifier | NCT06206265 |
| Trial Title | Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | DRUG: TRYP-0082|BEHAVIORAL: Psychotherapy |
Participant Information
| Sponsor | TRYP Therapeutics |
|---|---|
| City | Boston |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2024-01-17 |
|---|---|
| Primary Completion Date | 2026-03-01 |
| Completion Date | 2026-03-01 |